49
Views
5
CrossRef citations to date
0
Altmetric
Original Research

The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis

, , , &
Pages 1725-1734 | Published online: 21 Mar 2017

References

  • MickleyAKovalevaOKzhyshkowskaJGratchevAMolecular and immunologic markers of kidney cancer-potential applications in predictive, preventive and personalized medicineEPMA J201562026500709
  • KingSCPollackLALiJKingJBMasterVAContinued increase in incidence of renal cell carcinoma, especially in young patients and high grade disease: United States 2001 to 2010J Urol201419161665167024423441
  • CairnsPRenal cell carcinomaCancer Biomark201091–646147322112490
  • PanDXuLLiuHInterleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinomaJpn J Clin Oncol201545220220925420690
  • RiniBICampbellSCEscudierBRenal cell carcinomaLancet200937396691119113219269025
  • HuntJDvan der HelOLMcMillanGPBoffettaPBrennanPRenal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studiesInt J Cancer2005114110110815523697
  • YuanJMCastelaoJEGago-DominguezMYuMCRossRKTobacco use in relation to renal cell carcinomaCancer Epidemiol Biomarkers Prev1998754294339610793
  • van DijkBASchoutenLJKiemeneyLAGoldbohmRAvan den BrandtPARelation of height, body mass, energy intake, and physical activity to risk of renal cell carcinoma: results from the Netherlands Cohort StudyAm J Epidemiol2004160121159116715583368
  • BjorgeTTretliSEngelandARelation of height and body mass index to renal cell carcinoma in two million Norwegian men and womenAm J Epidemiol2004160121168117615583369
  • McLaughlinJKChowWHMandelJSInternational renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertensionInt J Cancer19956322162217591207
  • McCredieMPommerWMcLaughlinJKInternational renal-cell cancer study. II. AnalgesicsInt J Cancer19956033453497829242
  • MengFDMaPSuiCGTianXJiangYHAssociation between cytochrome P450 1A1 (CYP1A1) gene polymorphisms and the risk of renal cell carcinoma: a meta-analysisSci Rep20155810825630554
  • WangZWeiMRenYmiR149 rs71428439 polymorphism and risk of clear cell renal cell carcinoma: a case-control studyTumour Biol20143512121271213025213695
  • MengFMaPSuiCThe association between VDR polymorphisms and renal cell carcinoma susceptibility: a meta-analysisTumour Biol20143566065607224609903
  • MaNLiLWChengJLPredictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patientsOncol Lett20159265165625621033
  • YangSMHuangCYShiueHSJoint effect of urinary total arsenic level and VEGF-A genetic polymorphisms on the recurrence of renal cell carcinomaPLoS One20151012e014541026701102
  • JosephRWParasramkaMEckel-PassowJEInverse association between programmed death ligand 1 and genes in the VEGF pathway in primary clear cell renal cell carcinomaCancer Immunol Res20131637838524778130
  • KumarBRayKBReddyGVVEGF-C differentially regulates VEGF-A expression in ocular and cancer cells; promotes angiogenesis via RhoA mediated pathwayAngiogenesis201114337138021698469
  • CarmelietPVEGF as a key mediator of angiogenesis in cancerOncology200569suppl 341016301830
  • BadalSAAikenWDChinSNMolecular targets and angiogenesis in renal cell carcinoma, a multi-target approach: mini reviewCurr Drug Targets Epub201652
  • VincentiVCassanoCRocchiMPersicoGAssignment of the vascular endothelial growth factor gene to human chromosome 6p21.3Circulation1996938149314958608615
  • WatsonCJWebbNJBottomleyMJBrenchleyPEIdentification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein productionCytokine20001281232123510930302
  • PasqualettiGDanesiRDel TaccaMBocciGVascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapyPharmacogenomics200781496617187509
  • BianconiMFaloppiLLoretelliCAngiogenesis genotyping in the selection of first-line treatment with either sunitinib or pazopanib for advanced renal cell carcinomaOncotarget2016725375993760727175586
  • XianWZhengHWuWJPredictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomasGenet Mol Res20151437634764226214443
  • ShenBLQuQSMiaoSZZhangYXAssociation between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control studyGenet Mol Res2015143111191112526400342
  • Saenz-LopezPVazquezFCozarJMCarreteroRGarridoFRuiz-CabelloFVEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish populationHum Immunol20137419810323073296
  • RickettsCZeegersMPLubinskiJMaherERAnalysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinomaPLoS One200946e603719551141
  • LuGDongYZhangQJiaoLYangSShenBPredictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control studyTumour Biol201536118645865226044558
  • BruyereFHovensCMMarsonMNVEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaJ Urol201018441273127820723915
  • AjazSKhaliqSA bidAAssociation of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinomaGenet Test Mol Biomarkers201115965365721491998
  • AbeASatoKHabuchiTSingle nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinomaTohoku J Exp Med2002198318119012597245
  • ZhangYLiSXiaoHQHuZXXuYCHuangQVascular endothelial growth factor gene polymorphisms and renal cell carcinoma: a systematic review and meta-analysisOncol Lett2013641068107824137466
  • HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
  • HigginsJPThompsonSGQuantifying heterogeneity in a meta-analysisStat Med200221111539155812111919
  • ChenZXuSXuWExpression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significanceOncol Lett201510272372926622560
  • WangXLAiZSFangJPTangRYChenXMExpression of vascular endothelial growth factors (VEGF)-A, -C and -D and their prognostic significance and relationship with angio- and lymphangiogenesis in gastric cancerZhonghua Zhong Liu Za Zhi2008301183784319173829
  • ChenWHeDLiZZhangXPanDChenGOverexpression of vascular endothelial growth factor indicates poor outcomes of glioma: a systematic review and meta-analysisInt J Clin Exp Med2015868709871926309522
  • LeeJSKimHSJungJJParkCSLeeMCExpression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expressionJ Surg Oncol2001771556011344484
  • NeufeldGCohenTGengrinovitchSPoltorakZVascular endothelial growth factor (VEGF) and its receptorsFASEB J19991319229872925
  • OginoSLochheadPChanATMolecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseMod Pathol201326446548423307060
  • HamadaTKeumNNishiharaROginoSMolecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesisJ Gastroenterol201752326527527738762
  • OginoSNishiharaRVanderWeeleTJReview article: the role of molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicineEpidemiology201627460261126928707
  • ShuXLinJWoodCGTannirNMWuXEnergy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma riskJ Natl Cancer Inst2013105642443223378641